Patent: 7,423,135
✉ Email this page to a colleague
Summary for Patent: 7,423,135
Title: | .beta.-actin and rpS21 promoters and uses thereof |
Abstract: | The invention relates to isolation of novel .beta.-actin and ribosomal protein S21 (rpS21) promoters and uses thereof. In particular, this invention features nucleotide sequences for rodent .beta.-actin promoters including, hamster, rat, and mouse, and hamster rpS21 promoter. |
Inventor(s): | Estes; Scott D. (Framingham, MA), Zhang; Weiqun (Southborough, MA) |
Assignee: | Genzyme Corporation (Cambridge, MA) |
Application Number: | 10/874,242 |
Patent Claims: | see list of patent claims |
Details for Patent 7,423,135
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genzyme Corporation | THYROGEN | thyrotropin alfa | For Injection | 020898 | 11/30/1998 | ⤷ Try a Trial | 2023-06-24 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |